This article provides quick answers to common questions patients may ask about the COVID-19 vaccination.
This summary is based on the information in COVID-19: the green book, chapter 14a and focuses on the Pfizer BioNTech COVID-19 vaccine, approved on 02 December, and the Oxford–AstraZeneca COVID-19 vaccine, which is undergoing phase 3 trials.
Common questions about COVID-19 vaccination
- Doctor I have a bleeding disorder, should I be concerned?
- What should be done if a patient’s vaccination course is interrupted?
- Is a booster dose required after the two doses?
- Can I have the COVID-19 vaccine with other vaccines?
- Is the vaccine safe in pregnancy or when breastfeeding?
- Is the vaccine safe in children?
- Is the vaccine safe in those with immunosuppression or HIV?
- What are the contraindications to use of the vaccine?
- What happens if the patient has a minor illness?
- What adverse events should patients be warned about?
- Is there any reported anaphylaxis or other allergic reactions?
- Can vaccination be used if a patient exposed to COVID-19?
To view full article register to OnMedica and then click
'View full content'.
For a comparison of the key characteristics of each vaccine, you can also access our practical reference table, which you can download: